Funded Grants

Grants awarded in the current fiscal year and carried over from prior fiscal years.

PI Name	PI Organization	Title	Grant Number	Initiative	Program Official Sort descending
Shiozawa, Yusuke	Wake Forest University Health Sciences United States	Contribution of cutaneous neuro-immune interactions to chemotherapy-induced peripheral neuropathy	5R21CA297068-02		Rachel Altshuler, Ph.D.
Ross, Stephen	New York University School Of Medicine United States	Psilocybin Therapy for Advanced Cancer-related Psychiatric Distress	5R01CA268521-04		Rachel Altshuler, Ph.D.
Hu, Shuiying	Ohio State University United States	Targeting neuronal transport to ameliorate vincristine neurotoxicity	5R01CA272254-03		Rachel Altshuler, Ph.D.
Spiegel, Brennan	Cedars-Sinai Medical Center United States	Randomized Controlled Trial of Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes	5R01CA252211-05		Rachel Altshuler, Ph.D.
Salvemini, Daniela	Saint Louis University United States	Fingolimod and Ozanimod for the treatment and prevention of chemobrain	5R01CA261979-04		Rachel Altshuler, Ph.D.
Vijayvergia, Namrata	Research Inst Of Fox Chase Can Ctr United States	Exploring the Neuroprotective Potential of CBD in Preventing Oxaliplatin-Induced Neuropathy: A Prospective Study	1R21CA292276-01A1		Rachel Altshuler, Ph.D.
Staff, Nathan P	Mayo Clinic Rochester United States	Investigating the role of MAP2 in chemotherapy-induced peripheral neurotoxicity	5R01CA275870-04	PAR-21-329 (R01 Clinical Trial Optional)	Rachel Altshuler, Ph.D.
Buczynski, Matthew Wallace	Virginia Polytechnic Inst And St Univ United States	Anti-nociceptive actions of CART II in chemotherapy-induced peripheral neuropathy	5R01CA284075-03		Rachel Altshuler, Ph.D.
Yang, Qing	University Of Texas Med Br Galveston United States	The role of acute excitation of sensory neurons in the development of paclitaxel-induced peripheral neuropathy	5R01CA273001-02		Rachel Altshuler, Ph.D.
Johnson, Constance Margaret	University Of Texas Hlth Sci Ctr Houston United States	Auricular Point Acupressure to Manage Chemotherapy Induced Neuropathy	3R01CA245054-05S1		Rachel Altshuler, Ph.D.